Semaglutide Weight Loss Program

Overview

Before its introduction as a highly effective long-term weight management solution, semaglutide (Ozempic) was used to treat type 2 diabetes. Physicians observed that while Ozempic increased insulin production and reduced blood sugar levels, it also produced significant weight loss results. The makers of Ozempic, Novo Nordisk, conducted numerous clinical studies before offering their breakthrough weight loss medication called Wegovy, now FDA-approved for weight management.

Semaglutide is ideal for individuals with a body mass index (BMI) of 30 or greater or adults with a BMI of 27 and at least one complication related to body weight, such as hypertension, insulin resistance, high cholesterol, or heart disease.

How it works:

Semaglutide is a type of medication called a glucagon-like peptide-1 (GLP-1) agonist, which mimics the hormone GLP-1 that the body naturally produces. The breakthrough weight loss solution lowers blood sugar levels after meals. It regulates blood sugar by stimulating glucose-dependent insulin secretion.

Semaglutide slows down the release of sugar into your blood, so your body burns more fat. It also delays stomach emptying, leaving you feeling fuller longer and limiting your overall calorie consumption.

Several clinical studies show that weekly Semaglutide injections are highly effective at promoting weight loss. In one study, individuals treated with Semaglutide lost an average of 9-13 percent of their body weight over the course of a year without making any changes to their diet and exercise habits.

Once-weekly injectable medication
Delays stomach emptying
Increases the feeling of fullness
Decreases appetite
Slows intestinal motility
Lowers blood sugar levels
Stimulates insulin secretion
Reduces the risk of chronic health conditions
Comes with minimal side effects
Safe under medical supervision

Is it safe?

Semaglutide is safe under medical supervision, producing far fewer side effects than most other weight loss medications. Some individuals report gastrointestinal upset, including nausea, stomach pain, diarrhea, or constipation. To avoid these side effects, we add vitamin B6 to your treatment. We also start you off at a low dosage of Semaglutide and slowly increase it over time until we reach the ideal dosage for weight loss.

If you have type-1 diabetes or pancreatitis or if you or a family member have a history of thyroid cancer, we may recommend other weight loss solutions. Make sure to let us know about any health concerns to determine whether Semaglutide is suitable for you.

Side effects:

Potential side effects to be aware of? Gastrointestinal (GI) side effects tend to happen most frequently when using this medication — the most common being nausea, constipation, and vomiting.You may experience these effects more strongly when your provider raises your dose.

Additional common side effects can include:

Stomach pain
Indigestion
Bloating

How do I deal with nausea or constipation?

small, frequent meals
lower the amount of alcohol you consume
low fat meals
bland diet-bananas, rice, toast
Ginger, Unisom, Vitamin B6 for nausea
Prescription for Zofran is also available upon request

WHO IS NOT A CANDIDATE FOR SEMAGLUTIDE?

< 18 years old
Pregnant/breastfeeding
Type 1 diabetes mellitus
Hypersensitivity to semaglutide or any components of this medication Personal or family history of medullary thyroid carcinoma
History of multiple endocrine neoplasia syndrome
History of pancreatitis
End stage renal disease (on dialysis)
BMI<25
Type 2 diabetic patients that are on insulin or a sulfonylurea
Patients with diabetic retinopathy
Patients with that are on several antihypertensive medications

WHO IS A CANDIDATE?

Everyone else*

*Health history, medications and body weight information will be carefully reviewed by a licensed provider to determine each candidate’s eligibility.

Dosing schedule:

Weeks 1-4 0.25mg

Weeks 5-8 0.5.mg

Weeks 9-12 1.0 mg

Weeks 13-16 1.7 mg

Weeks 18-22 2.4 mg

Maintenance dose can purchased at Upon request. Recommended every 2-4 weeks to maintain weight loss

Weight loss program includes:

Initial consultation with NP to reviewed medical history
Weekly subcutaneous injections
Weigh ins

Learn More

Tirzepatide Weight Loss Program

Overview

Tirzepatide is a peptide that works by activating certain receptors in the body that play a role in regulating appetite and metabolism. In clinical trials, tirzepatide has been shown to produce significant weight loss in individuals with obesity, as well as improvements in other markers of health such as blood sugar control and cardiovascular risk factors.

Tirzepatide is unique because it is the first medication that combines two classes of medication: a glucagon-like peptide-1 (GLP-1) receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. This makes tirzepatide a dual GLP-1/GIP receptor agonist. Together, these functions can help reduce hunger, causing you to eat less food and lose more weight

How it works:

As a dual glucose-dependent insulinotropic polypeptide GIP and GLP-1 agonist, tirzepatide has been shown in clinical studies to aid in weight reduction. Tirzepatide produces its weight loss results through the following mechanisms of action:

Appetite Suppression

Tirzepatide affects the brain's appetite-regulating centers, resulting in less hunger and a longer sense of fullness. This can lead to a reduction in food intake.

Slowed Gastric Emptying

Tirzepatide delays stomach emptying, which might cause food to take longer to travel through the digestive system. This delay in stomach emptying can also promote satiety and aid in food intake management.

Improved Insulin Sensitivity

Tirzepatide enhances insulin sensitivity, which means that the cells in the body are more sensitive to the actions of insulin. Increased insulin sensitivity can improve glucose absorption by cells while decreasing glucose synthesis by the liver. This kind of healthy blood sugar regulation is important for weight loss.

Increased Energy Expenditure

Tirzepatide has been linked to an increase in increased physical activity. Weight loss is inevitable if the body burns more calories than the caloric intake.

Lipolysis

Tirzepatide has been proven to increase fat cell breakdown, also known as lipolysis. Releasing stored fat to produce energy is fundamental for weight loss.

It's crucial to note that the weight reduction benefits of tirzepatide vary from person to person, and researchers have mostly examined it in type 2 diabetes patients specifically. Individuals may have different processes and proportional contributions to weight reduction.Is it safe?

Side effects:

Additional common side effects can include:

Stomach pain
Indigestion
Bloating

How do I deal with nausea or constipation?

small, frequent meals
lower the amount of alcohol you consume
low fat meals
bland diet-bananas, rice, toast
Ginger, Unisom, Vitamin B6 for nausea
Prescription for Zofran is also available upon request

WHO IS NOT A CANDIDATE FOR TIRZEPATIDE?

< 18 years old
Pregnant/breastfeeding
Type 1 diabetes mellitus
Hypersensitivity to semaglutide or any components of this medication Personal or family history of medullary thyroid carcinoma
History of multiple endocrine neoplasia syndrome
History of pancreatitis
End stage renal disease (on dialysis)
BMI<25
Type 2 diabetic patients that are on insulin or a sulfonylurea
Patients with diabetic retinopathy
Patients with that are on several antihypertensive medications

WHO IS A CANDIDATE?

Everyone else*

*Health history, medications and body weight information will be carefully reviewed by a licensed provider to determine each candidate’s eligibility.

Dosing schedule:

Weeks 1-4 2.5mg

Weeks 5-8 5mg

Weeks 9-12 7.5mg

Weeks 13-16 10 mg

Weeks 18-22 12.5mg

Weeks 23-26 15mg

Maintenance dose can purchased Upon request. Recommended every 2-4 weeks to maintain weight loss